Capital International LTD Regeneron Pharmaceuticals, Inc. Transaction History

Capital International LTD

$2.23 Billion
Q3 2024

A detailed history of Capital International LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Capital International LTD holds 35,771 shares of REGN stock, worth $27 Million. This represents 1.69% of its overall portfolio holdings.

Number of Shares

35,771

Previous 34,774 2.87%

Holding current value

$27 Million

Previous $36.5 Million 2.89%

% of portfolio

1.69%

Previous 1.75%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1024.09 - $1201.76 $1.02 Million - $1.2 Million	997 Added 2.87%	35,771 $37.6 Million
Q2 2024 Aug 13, 2024	BUY	$883.2 - $1071.19 $3.3 Million - $4.01 Million	3,741 Added 12.05%	34,774 $36.5 Million
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $6.33 Million - $6.96 Million	7,007 Added 29.16%	31,033 $29.9 Million
Q4 2023 Feb 13, 2024	BUY	$775.18 - $881.7 $359,683 - $409,108	464 Added 1.97%	24,026 $21.1 Million
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $3.33 Million - $4.06 Million	-4,806 Reduced 16.94%	23,562 $19.4 Million
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $2.04 Million - $2.42 Million	-2,919 Reduced 9.33%	28,368 $20.4 Million
Q1 2023 May 15, 2023	SELL	$680.49 - $826.97 $411,015 - $499,489	-604 Reduced 1.89%	31,287 $25.7 Million
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $422,122 - $458,301	-598 Reduced 1.84%	31,891 $23 Million
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $1.98 Million - $2.5 Million	3,446 Added 11.87%	32,489 $22.4 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $760,561 - $1.02 Million	1,387 Added 5.02%	29,043 $17.2 Million
Q1 2022 May 16, 2022	BUY	$595.12 - $698.43 $1.89 Million - $2.21 Million	3,171 Added 12.95%	27,656 $19.3 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $56,521 - $69,780	104 Added 0.43%	24,485 $15.5 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $165,320 - $196,116	-288 Reduced 1.17%	24,381 $14.8 Million
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $538,519 - $636,177	-1,139 Reduced 4.41%	24,669 $13.8 Million
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $1.17 Million - $1.43 Million	-2,616 Reduced 9.2%	25,808 $12.2 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $152,577 - $193,945	319 Added 1.14%	28,424 $13.7 Million
Q3 2020 Nov 13, 2020	BUY	$544.75 - $658.21 $2.62 Million - $3.16 Million	4,803 Added 20.61%	28,105 $15.7 Million
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $130,236 - $169,994	-264 Reduced 1.12%	23,302 $14.5 Million
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $7.92 Million - $11.7 Million	23,566 New	23,566 $11.5 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $2.89 Million - $3.36 Million	-8,223 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$284.6 - $344.99 $28,175 - $34,154	-99 Reduced 1.19%	8,223 $2.84 Million
Q1 2018 May 15, 2018	BUY	$315.82 - $393.78 $2.63 Million - $3.28 Million	8,322 New	8,322 $2.87 Million

Others Institutions Holding REGN

# of Institutions

1,532

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $80.9B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International LTD , based on Form 13F filings with the SEC.

News

Stay updated on Capital International LTD with notifications on news.

Account

Capital International LTD Regeneron Pharmaceuticals, Inc. Transaction History